High Purity New England Supports Drug Development Pipelines with Fully Customizable and Flexible Single-Use Assembly Solution
Demand for single-use assembly solutions in the biopharma industry continues to increase, with the market expected to be worth $26.89 billion by 2025.
The post High Purity New England Supports Drug Development Pipelines with Fully Customizable and Flexible Single-Use Assembly Solution appeared first on Fluid Handling Pro.
Source of Article